Molecular mechanisms of opioid tolerance: From opioid receptors to inflammatory mediators (Review)
- Authors:
- Jie Zhou
- Ruijie Ma
- Ying Jin
- Junfan Fang
- Junying Du
- Xiaomei Shao
- Yi Liang
- Jianqiao Fang
-
Affiliations: Department of Acupuncture and Moxibustion, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310005, P.R. China, Department of Rehabilitation in Traditional Chinese Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000, P.R. China, The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China - Published online on: July 15, 2021 https://doi.org/10.3892/etm.2021.10437
- Article Number: 1004
-
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Yongjun Z, Tingjie Z, Xiaoqiu Y, Zhiying F, Feng Q, Guangke X, Jinfeng L, Fachuan N, Xiaohong J and Yanqing L: A survey of chronic pain in China. Libyan J Med. 15(1730550)2020.PubMed/NCBI View Article : Google Scholar | |
|
Mills SEE, Nicolson KP and Smith BH: Chronic pain: A review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 123:e273–e283. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Strand EB, Mengshoel AM, Sandvik L, Helland IB, Abraham S and Nes LS: Pain is associated with reduced quality of life and functional status in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Scand J Pain. 19:61–72. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Chou R, Hartung D, Turner J, Blazina I, Chan B, Levander X, McDonagh M, Selph S, Fu R and Pappas M: Opioid Treatments for Chronic Pain. Agency for Healthcare Research and Quality (US), Rockville, MD, 2020. | |
|
Daoust R, Paquet J, Cournoyer A, Piette E, Morris J, Lessard J, Castonguay V, Williamson D and Chauny JM: Side effects from opioids used for acute pain after emergency department discharge. Am J Emerg Med. 38:695–701. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Roggeri D, Saramin C, Terrazzani G, Zusso M, Giusti P and Chinellato A: Resource consumption and costs of treating pain in patients affected by cancer in a district of northeast Italy. Pharmacol Res. 56:329–334. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Ahlbeck K: Opioids: A two-faced Janus. Curr Med Res Opin. 27:439–448. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Eidson LN and Murphy AZ: Inflammatory mediators of opioid tolerance: Implications for dependency and addiction. Peptides. 115:51–58. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Gulur P, Williams L, Chaudhary S, Koury K and Jaff M: Opioid tolerance-a predictor of increased length of stay and higher readmission rates. Pain Physician. 17:E503–E507. 2014.PubMed/NCBI | |
|
Martyn JAJ, Mao J and Bittner EA: Opioid tolerance in critical illness. N Engl J Med. 380:365–378. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Allouche S, Noble F and Marie N: Opioid receptor desensitization: Mechanisms and its link to tolerance. Front Pharmacol. 5(280)2014.PubMed/NCBI View Article : Google Scholar | |
|
Rosenblum A, Marsch LA, Joseph H and Portenoy RK: Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Exp Clin Psychopharmacol. 16:405–416. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Uniyal A, Gadepalli A and Akhilesh Tiwari V: Underpinning the neurobiological intricacies associated with opioid tolerance. ACS Chem Neurosci. 11:830–839. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liang Y, Chu H, Jiang Y and Yuan L: Morphine enhances IL-1β release through toll-like receptor 4-mediated endocytic pathway in microglia. Purinergic Signal. 12:637–645. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Sanna MD, Borgonetti V and Galeotti N: µ Opioid receptor-triggered notch-1 activation contributes to morphine tolerance: Role of neuron-glia communication. Mol Neurobiol. 57:331–345. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang X, Loram LC, Ramos K, de Jesus AJ, Thomas J, Cheng K, Reddy A, Somogyi AA, Hutchinson MR, Watkins LR and Yin H: Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc Natl Acad Sci USA. 109:6325–6330. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, et al: A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. The Journal of neuroscience: J Neurosci. 24:7353–7365. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Wang H, Zhang Y, Ma X, Wang W, Xu X, Huang M, Xu L, Shi H, Yuan T, Jiang W, et al: Spinal TLR4/P2X7 receptor-dependent NLRP3 inflammasome activation contributes to the development of tolerance to morphine-induced antinociception. J Inflamm Res. 13:571–582. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Pasternak GW and Pan YX: Mu opioids and their receptors: Evolution of a concept. Pharmacol Rev. 65:1257–1317. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Yam MF, Loh YC, Tan CS, Khadijah Adam S, Abdul Manan N and Basir R: General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Int J Mol Sci. 19(2164)2018.PubMed/NCBI View Article : Google Scholar | |
|
McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J and Carr D: Americal Pain Society. Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review. J Pain. 4:231–256. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Dougall IG: A critical review of the classification of opioid receptors. Biotechnol Appl Biochem. 10:488–499. 1988.PubMed/NCBI | |
|
Pert CB and Snyder SH: Opiate receptor: Demonstration in nervous tissue. Science. 179:1011–1014. 1973.PubMed/NCBI View Article : Google Scholar | |
|
Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK and Granier S: Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature. 485:321–326. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ and Christie MJ: Regulation of µ-opioid receptors: Desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 65:223–254. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Chavkin C, McLaughlin JP and Celver JP: Regulation of opioid receptor function by chronic agonist exposure: Constitutive activity and desensitization. Mol Pharmacol. 60:20–25. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Schulz S, Mayer D, Pfeiffer M, Stumm R, Koch T and Hollt V: Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J. 23:3282–3289. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Clayton CC, Bruchas MR, Lee ML and Chavkin C: Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy. Mol Pharmacol. 77:339–347. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Lau EK, Trester-Zedlitz M, Trinidad JC, Kotowski SJ, Krutchinsky AN, Burlingame AL and von Zastrow M: Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection. Sci Signal. 4(ra52)2011.PubMed/NCBI View Article : Google Scholar | |
|
Arttamangkul S, Heinz DA, Bunzow JR, Song X and Williams JT: Cellular tolerance at the micro-opioid receptor is phosphorylation dependent. Elife. 7(e34989)2018.PubMed/NCBI View Article : Google Scholar | |
|
Birdsong WT, Arttamangkul S, Bunzow JR and Williams JT: Agonist binding and desensitization of the µ-opioid receptor is modulated by phosphorylation of the C-terminal tail domain. Mol Pharmacol. 88:816–824. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Fan T, Varghese G, Nguyen T, Tse R, O'Dowd BF and George SR: A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J Biol Chem. 280:38478–38488. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE and Devi LA: A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci USA. 101:5135–5139. 2004.PubMed/NCBI View Article : Google Scholar | |
|
He SQ, Zhang ZN, Guan JS, Liu HR, Zhao B, Wang HB, Li Q, Yang H, Luo J, Li ZY, et al: Facilitation of µ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. Neuron. 69:120–131. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Wang D, Tawfik VL, Corder G, Low SA, Francois A, Basbaum AI and Scherrer G: functional divergence of delta and mu opioid receptor organization in CNS pain circuits. Neuron. 98:90–108, e5. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Chefer VI and Shippenberg TS: Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice. Neuropsychopharmacology. 34:887–898. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Fujita W, Gomes I and Devi LA: Heteromers of µ-δ opioid receptors: new pharmacology and novel therapeutic possibilities. Br J Pharmacol. 172:375–387. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Schiller PW: Opioid peptide-derived analgesics. AAPS J. 7:E560–E565. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, O'Donnell D, Kieffer BL and Basbaum AI: Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell. 137:1148–1159. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP, Unterwald E, Pasternak GW and Pintar JE: Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron. 24:243–252. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Guo J, Wu Y, Zhang W, Zhao J, Devi LA, Pei G and Ma L: Identification of G protein-coupled receptor kinase 2 phosphorylation sites responsible for agonist-stimulated delta-opioid receptor phosphorylation. Mol Pharmacol. 58:1050–1056. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Al-Hasani R and Bruchas MR: Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 115:1363–1381. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Xie WY, He Y, Yang YR, Li YF, Kang K, Xing BM and Wang Y: Disruption of Cdk5-associated phosphorylation of residue threonine-161 of the delta-opioid receptor: Impaired receptor function and attenuated morphine antinociceptive tolerance. J Neurosci. 29:3551–3564. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Jean-Charles PY, Kaur S and Shenoy SK: G Protein-coupled receptor signaling through β-arrestin-dependent mechanisms. J Cardiovasc Pharmacol. 70:142–158. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, Huang P, Li JG, Cowan A and Liu-Chen LY: Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. J Pharmacol Exp Ther. 312:220–230. 2005.PubMed/NCBI View Article : Google Scholar | |
|
McLaughlin JP, Myers LC, Zarek PE, Caron MG, Lefkowitz RJ, Czyzyk TA, Pintar JE and Chavkin C: Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J Biol Chem. 279:1810–1818. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Lalanne L, Ayranci G, Kieffer BL and Lutz PE: The kappa opioid receptor: From addiction to depression, and back. Front Psychiatry. 5(170)2014.PubMed/NCBI View Article : Google Scholar | |
|
Lutz PE and Kieffer BL: Opioid receptors: Distinct roles in mood disorders. Trends Neurosci. 36:195–206. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Nygard SK, Hourguettes NJ, Sobczak GG, Carlezon WA and Bruchas MR: Stress-induced reinstatement of nicotine preference requires dynorphin/kappa opioid activity in the basolateral amygdala. J Neurosci. 36:9937–9948. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Taylor GT and Manzella F: Kappa opioids, salvinorin a and major depressive disorder. Curr Neuropharmacol. 14:165–176. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Sheffler DJ and Roth BL: Salvinorin A: The ‘magic mint’ hallucinogen finds a molecular target in the kappa opioid receptor. Trends Pharmacol Sci. 24:107–109. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA, Hufeisen SJ and Roth BL: Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: Structural and functional considerations. J Pharmacol Exp Ther. 308:1197–1203. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Mollereau C and Mouledous L: Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides. 21:907–917. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Thompson AA, Liu W, Chun E, Katritch V, Wu H, Vardy E, Huang XP, Trapella C, Guerrini R, Calo G, et al: Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature. 485:395–399. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Chen Y, Fan Y, Liu J, Mestek A, Tian M, Kozak CA and Yu L: Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347:279–283. 1994.PubMed/NCBI View Article : Google Scholar | |
|
Mogil JS and Pasternak GW: The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev. 53:381–415. 2001.PubMed/NCBI | |
|
Spampinato S, Baiula M and Calienni M: Agonist-regulated internalization and desensitization of the human nociceptin receptor expressed in CHO cells. Curr Drug Targets. 8:137–146. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Zaveri NT: Nociceptin opioid receptor (NOP) as a therapeutic target: Progress in translation from preclinical research to clinical utility. J Med Chem. 59:7011–7028. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Zamponi GW and Snutch TP: Modulating modulation: Crosstalk between regulatory pathways of presynaptic calcium channels. Mol Interv. 2:476–478. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Zamponi GW and Snutch TP: Modulation of voltage-dependent calcium channels by G proteins. Curr Opin Neurobiol. 8:351–356. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Torrecilla M, Quillinan N, Williams JT and Wickman K: Pre- and postsynaptic regulation of locus coeruleus neurons after chronic morphine treatment: A study of GIRK-knockout mice. Eur J Neurosci. 28:618–624. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Diaz A, Florez J, Pazos A and Hurle MA: Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system. Pain. 86:227–235. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Bohn LM, Lefkowitz RJ and Caron MG: Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci. 22:10494–10500. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Bernstein MA and Welch SP: mu-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Brain Res Mol Brain Res. 55:237–242. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Stafford K, Gomes AB, Shen J and Yoburn BC: mu-Opioid receptor downregulation contributes to opioid tolerance in vivo. Pharmacol Biochem Behav. 69:233–237. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Fábián G, Bozó B, Szikszay M, Horváth G, Coscia CJ and Szücs M: Chronic morphine-induced changes in mu-opioid receptors and G proteins of different subcellular loci in rat brain. J Pharmacol Exp Ther. 302:774–780. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Gupta S and Kulhara P: Cellular and molecular mechanisms of drug dependence: An overview and update. Indian J Psychiatry. 49:85–90. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Chakrabarti S, Liu NJ and Gintzler AR: Phosphorylation of unique C-terminal sites of the mu-opioid receptor variants 1B2 and 1C1 influences their Gs association following chronic morphine. J Neurochem. 152:449–467. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kelley N, Jeltema D, Duan Y and He Y: The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int J Mol Sci. 20(3328)2019.PubMed/NCBI View Article : Google Scholar | |
|
Jha MK, Jeon S and Suk K: Glia as a link between neuroinflammation and neuropathic pain. Immune Netw. 12:41–47. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Pinho-Ribeiro FA, Verri WA Jr and Chiu IM: Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 38:5–19. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Shavit Y, Wolf G, Goshen I, Livshits D and Yirmiya R: Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain. 115:50–59. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Lacagnina MJ, Watkins LR and Grace PM: Toll-like receptors and their role in persistent pain. Pharmacol Ther. 184:145–158. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Eidson LN, Inoue K, Young LJ, Tansey MG and Murphy AZ: Toll-like receptor 4 mediates morphine-induced neuroinflammation and tolerance via soluble tumor necrosis factor signaling. Neuropsychopharmacology. 42:661–670. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Illes P, Rubini P, Ulrich H, Zhao Y and Tang Y: Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS. Cells. 9(1108)2020.PubMed/NCBI View Article : Google Scholar | |
|
Mohan S, Davis RL, DeSilva U and Stevens CW: Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1beta: Evidence for opioid-immune crosstalk. J Neuroimmunol. 227:26–34. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Ruzicka BB and Akil H: The interleukin-1beta-mediated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures. Neuroscience. 79:517–524. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Liu DQ, Zhou YQ and Gao F: targeting cytokines for morphine tolerance: A narrative review. Curr Neuropharmacol. 17:366–376. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Allan SM, Tyrrell PJ and Rothwell NJ: Interleukin-1 and neuronal injury. Nat Rev Immunol. 5:629–640. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Park JI, Strock CJ, Ball DW and Nelkin BD: Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. Cytokine. 29:125–134. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Chen ML, Cao H, Chu YX, Cheng LZ, Liang LL, Zhang YQ and Zhao ZQ: Role of P2X7 receptor-mediated IL-18/IL-18R signaling in morphine tolerance: Multiple glial-neuronal dialogues in the rat spinal cord. J Pain. 13:945–958. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Janeway CA Jr and Medzhitov R: Innate immune recognition. Annu Rev Immunol. 20:197–216. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Akira S, Uematsu S and Takeuchi O: Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, Slivka PF, Coats BD, Rezvani N, Wieseler J, et al: Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun. 24:83–95. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Eidson LN and Murphy AZ: Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine. J Neurosci. 33:15952–15963. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Liu Y, Dai Y, Li Q, Chen C, Chen H, Song Y, Hua F and Zhang Z: Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia. Neurosci Lett. 736(135279)2020.PubMed/NCBI View Article : Google Scholar | |
|
de Rivero Vaccari JP, Dietrich WD and Keane RW: Activation and regulation of cellular inflammasomes: Gaps in our knowledge for central nervous system injury. J Cereb Blood Flow Metab. 34:369–375. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Kleibeuker W, Gabay E, Kavelaars A, Zijlstra J, Wolf G, Ziv N, Yirmiya R, Shavit Y, Tal M and Heijnen CJ: IL-1 beta signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2. Brain Behav Immun. 22:200–208. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Grace PM, Loram LC, Christianson JP, Strand KA, Flyer-Adams JG, Penzkover KR, Forsayeth JR, van Dam AM, Mahoney MJ, Maier SF, et al: Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy. Brain Behav Immun. 59:49–54. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Grace PM, Strand KA, Galer EL, Urban DJ, Wang X, Baratta MV, Fabisiak TJ, Anderson ND, Cheng K, Greene LI, et al: Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation. Proc Natl Acad Sci USA. 113:E3441–E3450. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Cunha TM, Roman-Campos D, Lotufo CM, Duarte HL, Souza GR, Verri WA Jr, Funez MI, Dias QM, Schivo IR, Domingues AC, et al: Morphine peripheral analgesia depends on activation of the PI3Kgamma/AKT/nNOS/NO/KATP signaling pathway. Proc Natl Acad Sci USA. 107:4442–4447. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Roeckel LA, Le Coz GM, Gaveriaux-Ruff C and Simonin F: Opioid-induced hyperalgesia: Cellular and molecular mechanisms. Neuroscience. 338:160–182. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Jeffery MM, Chaisson CE, Hane C, Rumanes L, Tucker J, Hang L, McCoy R, Chen CL, Bicket MC, Hooten WM, et al: Assessment of potentially inappropriate prescribing of opioid analgesics requiring prior opioid tolerance. JAMA Netw Open. 3(e202875)2020.PubMed/NCBI View Article : Google Scholar |
